Aptamers were first discovered in the early 90s, and have since been the focus of extensive research. These unique, single-stranded DNA or RNA molecules bind specifically to target molecules, revolutionizing therapeutics and diagnostics.
This tiny wonder offers numerous advantages due to their small size, stability, and ability to target various molecules, making them the perfect alternative to antibodies in several applications.
Milestones in Aptamer Research
1990
2001
2010
2020
